Articles from Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming January 16, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Gauzy Ltd. (“Gauzy” or the “Company”) (NASDAQ: GAUZ) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Paysafe Limited (“Paysafe” or the “Company”) (NYSE: PSFE) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of StubHub Holdings, Inc. (“StubHub” or the “Company”) (NYSE: STUB) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Six Flags Entertainment Corporation (“Six Flags” or the “Company”) (NYSE: FUN) common stock pursuant or traceable to the Company’s registration statement and prospectus issued in connection with the July 1, 2024 merger of Six Flags with Cedar Fair, L.P. (“Cedar Fair”), and their subsidiaries and affiliates.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of Primo Brands Corporation (“Primo Brands” or the “Company”) (NYSE: PRMB) investors who purchased or otherwise acquired: (1) Primo Water Corporation (“Primo Water”) common stock between June 17, 2024 and November 8, 2024, inclusive; and/or (2) Primo Brands common stock between November 11, 2024 and November 6, 2025, inclusive (the “Class Period”), Primo Brands investors have until January 12, 2026 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”). Freeport investors have until January 12, 2026 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming January 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX) securities between February 21, 2025 and August 28, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned French v. Perrigo Company plc, et al., Case No. 1:25-cv-09596, on behalf of persons and entities that purchased or otherwise acquired Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Six Flags Entertainment Corporation (“Six Flags” or the “Company”) (NYSE: FUN) common stock pursuant or traceable to the Company’s registration statement and prospectus issued in connection with the July 1, 2024 merger of Six Flags with Cedar Fair, L.P. (“Cedar Fair”), and their subsidiaries and affiliates. Six Flags investors have until January 5, 2026 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Alibaba Group Holding Ltd. (“Alibaba” or the “Company”) (NYSE: BABA) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Freeport-McMoRan Inc. (“Freeport” or the “Company”) (NYSE: FCX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Primo Brands Corporation (“Primo Brands” or the “Company”) (NYSE: PRMB) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). Inspire investors have until January 5, 2026 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Six Flags Entertainment Corporation (“Six Flags” or the “Company”) (NYSE: FUN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). Stride investors have until January 12, 2026 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX) securities between February 21, 2025 and August 28, 2025, inclusive (the “Class Period”). Telix investors have until January 9, 2026 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of the Wildermuth Fund (“Wildermuth” or the “Fund”) (NASDAQ: WESFX, WEFCX, WEIFX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of HelloFresh SE (“HelloFresh” or the “Company”) (OTC: HELFY, HLFFF) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming November 12, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired V.F. Corporation (“VFC” or the “Company”) (NYSE: VFC) securities between October 27, 2022 and May 20, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Trex Company, Inc. (“Trex” or the “Company”) (NYSE: TREX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Power Solutions International, Inc. (“Power Solutions” or the “Company”) (NASDAQ: PSIX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming December 29, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming December 23, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX) common stock (previously American Depositary Shares until the Company’s conversion to common stock on July 1, 2025) between May 20, 2025 and August 18, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming January 2, 2026 to deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired CarMax, Inc. (“CarMax” or the “Company”) (NYSE: KMX) securities between June 20, 2025 and September 24, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Period”). Avantor investors have until December 29, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired CarMax, Inc. (“CarMax” or the “Company”) (NYSE: KMX) securities between June 20, 2025 and September 24, 2025, inclusive (the “Class Period”). CarMax investors have until January 2, 2026 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP reminds investors of the upcoming December 30, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS) securities between December 4, 2024 and September 9, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX) common stock (previously American Depositary Shares until the Company’s conversion to common stock on July 1, 2025) between May 20, 2025 and August 18, 2025, inclusive (the “Class Period”). James Hardie investors have until December 23, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Kim v. Synopsis, Inc., et al., Case No. 3:25-cv-09410, on behalf of persons and entities that purchased or otherwise acquired Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS) securities between December 4, 2024 and September 9, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Varonis Systems, Inc. (“Varonis” or the “Company”) (NASDAQ: VRNS) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Nidec Corporation (“Nidec” or the “Company”) (OTC: NJDCY) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025, inclusive (the “Class Period”). MoonLake investors have until December 15, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”). Baxter investors have until December 15, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of F5, Inc. (“F5” or the “Company”) (NASDAQ: FFIV) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired aTyr Pharma Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired WPP plc (“WPP” or the “Company”) (NYSE: WPP) common stock between February 27, 2025 and July 8, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of United Homes Group, Inc. (“UHG” or the “Company”) (NASDAQ: UHG) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired WPP plc (“WPP” or the “Company”) (NYSE: WPP) common stock between February 27, 2025 and July 8, 2025, inclusive (the “Class Period”). WPP investors have until December 8, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired aTyr Pharma Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”). aTyr investors have until December 8, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zions Bancorporation, National Association (“Zions” or the “Company”) (NASDAQ: ZION) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Western Alliance Bancorporation (“Western Alliance” or the “Company”) (NASDAQ: WAL) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Jefferies Financial Group Inc. (“Jefferies” or the “Company”) (NYSE: JEF) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of WPP plc (“WPP” or the “Company”) (NYSE: WPP) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of aTyr Pharma Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Marex Group plc (“Marex” or the “Company”) (NASDAQ: MRX) securities between May 16, 2024 and August 5, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Narayanan v. Marex Group PLC, et al., Case No. 1:25-cv-08393, on behalf of persons and entities that purchased or otherwise acquired Marex Group plc (“Marex” or the “Company”) (NASDAQ: MRX) securities between May 16, 2024 and August 5, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Palantir Technologies Inc. (“Palantir” or the “Company”) (NASDAQ: PLTR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming December 2, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Central District of California, captioned Hindlemann v. Molina Healthcare, Inc., et al., Case No. 2:25-cv-09461, on behalf of persons and entities that purchased or otherwise acquired Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Firefly Aerospace Inc. (“Firefly” or the “Company”) (NASDAQ: FLY) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming November 18, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) securities between November 30, 2023 and July 3, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming November 18, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired KBR, Inc. (“KBR” or the “Company”) (NYSE: KBR) securities between May 6, 2025 and June 19, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming November 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fortinet, Inc. (“Fortinet” or the “Company”) (NASDAQ: FTNT) common stock between November 8, 2024 through August 6, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming November 20, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired RCI Hospitality Holdings, Inc. (“RCI” or the “Company”) (NASDAQ: RICK) securities between December 15, 2021 and September 16, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of CarMax, Inc. (CarMax or the Company) (NYSE: KMX) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP reminds investors of the upcoming November 12, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired V.F. Corporation (“VFC” or the “Company”) (NYSE: VFC) securities between October 30, 2023 and May 20, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP reminds investors of the upcoming November 14, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR) securities between February 18, 2025 and July 31, 2025, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) securities between November 30, 2023 and July 3, 2025, inclusive (the “Class Period”). Jasper investors have until November 18, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fortinet, Inc. (“Fortinet” or the “Company”) (NASDAQ: FTNT) common stock between November 8, 2024 through August 6, 2025, inclusive (the “Class Period”). Fortinet investors have until November 21, 2025 to file a lead plaintiff motion.